Cisatracurium Besylate Injection
Product Images NDC 70069-141

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Cisatracurium Besylate (NDC 70069-141). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Somerset Therapeutics, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

D1a742e1 8c8c 4de0 9ea0 9c38961d18b6 01

Chemical structure of Cisatracurium Besylate, illustrating its molecular components including benzene rings with methoxy groups and the besylate counterion.*

FDA Label Image

D1a742e1 8c8c 4de0 9ea0 9c38961d18b6 02

A scatter plot chart showing data points centered around the origin with axes labeled HR (heart rate) vertically and MAP (mean arterial pressure) horizontally. The chart depicts percentage changes ranging from -60% to +60% on both axes.*

FDA Label Image

D1a742e1 8c8c 4de0 9ea0 9c38961d18b6 03

A scatter plot chart depicting data points related to heart rate (HR) on the vertical axis and mean arterial pressure (MAP) on the horizontal axis, each axis ranging from -60% to +60% change. The graph shows distribution of values around the origin with no axis labels beyond these measures.*

FDA Label Image

D1a742e1 8c8c 4de0 9ea0 9c38961d18b6 04

Label for Cisatracurium Besylate Injection, USP, showing a 10 mg/5 mL (2 mg/mL) strength in a 5 mL single-dose vial. The label includes a warning about its paralyzing effects and need for respiratory support, storage instructions at 2 to 8°C, and manufacturer information for Somerset Therapeutics, LLC, Hollywood, FL. The product is made in India.*

FDA Label Image

D1a742e1 8c8c 4de0 9ea0 9c38961d18b6 05

Cisatracurium Besylate Injection, USP 10 mg/5 mL (2 mg/mL) intravenous solution in a 5 mL single-dose vial. The label includes warnings of it being a paralyzing agent and instructions on storage and disposal. Labeler is Somerset Therapeutics, LLC. The packaging shows barcodes and lot/expiration date placeholders.*

FDA Label Image

D1a742e1 8c8c 4de0 9ea0 9c38961d18b6 06

Label for Cisatracurium Besylate Injection, USP 2 mg/mL (10 mg/5 mL) intravenous injection by Somerset Therapeutics, LLC. The label includes a warning that it is a paralyzing agent. The package contains 10 single-dose vials of 5 mL each. It also states storage instructions and manufacturer information.*

FDA Label Image

D1a742e1 8c8c 4de0 9ea0 9c38961d18b6 07

Cisatracurium Besylate Injection, USP label for 200 mg/20 mL (10 mg/mL) single-dose vial. The label includes warnings that it is a paralyzing agent causing respiratory arrest, intended for intravenous use only. Storage instructions specify 2° to 8°C (36° to 46°F) in carton, avoiding freezing and light exposure. Manufactured for Somerset Therapeutics, LLC, Hollywood, FL, and made in India.*

FDA Label Image

D1a742e1 8c8c 4de0 9ea0 9c38961d18b6 08

Cisatracurium Besylate Injection, USP 200 mg/20 mL (10 mg/mL) intravenous solution in single-dose vial packaging by Somerset Therapeutics, LLC. The label includes warnings about its paralyzing agent effect and respiratory arrest risk, storage instructions, and a note that it is for ICU use only.*

FDA Label Image

D1a742e1 8c8c 4de0 9ea0 9c38961d18b6 09

Label for Cisatracurium Besylate Injection, USP 200 mg/20 mL (10 mg/mL) intravenous injection by Somerset Therapeutics, LLC. The label includes dosing strength, warning of paralyzing agent and respiratory arrest risk, storage instructions, manufacturer details, and barcode. The package contains 10 single-dose vials of 20 mL each for ICU use only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.